semaglutide Archives - DeFuck Media

Verify Before You Inject: Understanding Compounded Peptide Safety

Verify Before You Inject: Understanding Compounded Peptide Safety

By Dr. Gabrielle Lyon July 30, 2026DeFuck Your Health

The importance of verifying the source and quality of compounded peptides. Understanding the role of peptides in metabolic and nutritional health. Insights into peptide safety and regulatory considerations. The implications…

The Future of Obesity Care: Beyond Ozempic, Wegovy, and Zepbound

The Future of Obesity Care: Beyond Ozempic, Wegovy, and Zepbound

By American Gastroenterological Association July 9, 2026Uncategorized

Summary of The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound: Experts believe that the future of obesity treatment will expand beyond GLP-1 medications like semaglutide (Wegovy…

Scientists Uncover Hidden Brain Pathway in GLP-1 Weight Loss

Scientists Uncover Hidden Brain Pathway in GLP-1 Weight Loss

By NIH/Office of the Director May 27, 2026Uncategorized

Summary of Scientists Identify Hidden Brain Pathway Behind GLP-1 Weight-Loss Effects: A recent NIH-funded study has revealed that oral GLP-1 weight-loss drugs can suppress pleasure-driven eating—known as hedonic eating—by targeting…

GLP-1 Weight Loss Significantly Reduces Risk of Sleep Apnea and Kidney Disease

GLP-1 Weight Loss Significantly Reduces Risk of Sleep Apnea and Kidney Disease

By European Association for the Study of Obesity May 13, 2026Uncategorized

Summary of GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More: Recent research presented at the European Congress on Obesity reveals that achieving and…

The Hidden Risks of Pausing Weight-Loss Medications Like Ozempic

The Hidden Risks of Pausing Weight-Loss Medications Like Ozempic

By University of Pennsylvania School of Medicine April 30, 2026Uncategorized

Summary of The Hidden Risk of Taking Breaks From Weight-Loss Drugs Like Ozempic: A recent study from the University of Pennsylvania suggests that inconsistent use of GLP-1 weight-loss medications, such…

New Hormone Discovery May Transform Arthritis Treatment

New Hormone Discovery May Transform Arthritis Treatment

By Aarhus University April 28, 2026Uncategorized

Summary of Unexpected Hormone Discovery Could Change How We Treat Arthritis: Researchers at Aarhus University have discovered the presence of the hormone GLP-1 in the joints of arthritis patients, suggesting…

Peptides Set to Explode: Essential Information You Need

Peptides Set to Explode: Essential Information You Need

By DeFuck Media April 19, 2026DeFuck Your Health

Peptides: What They Are and How They Function The Role of Peptides in Health and Metabolic Conditions Benefits of Peptides for Insulin Sensitivity and Weight Management Current Trends and Future…

New Study Explains Why Ozempic Varies in Effectiveness Among Users

New Study Explains Why Ozempic Varies in Effectiveness Among Users

By Frontiers April 7, 2026Uncategorized

Summary of New Study Reveals Why Ozempic Works Better for Some People Than Others: A recent study explored the effectiveness of GLP-1 receptor agonists like Ozempic for managing diabetes and…

Stopping Ozempic and Similar Weight-Loss Drugs Can Reverse Heart Benefits

Stopping Ozempic and Similar Weight-Loss Drugs Can Reverse Heart Benefits

By Washington University School of Medicine in St. Louis April 1, 2026Uncategorized

Summary of Stopping Weight-Loss Drugs Like Ozempic Can Quickly Erase Heart Benefits: A recent study highlights that GLP-1 drugs, widely used for diabetes and weight management, can lose their cardiovascular…

Study Warns: Stopping GLP-1 Weight Loss Drugs Can Cause Rapid Weight Gain and Heart Risks

Study Warns: Stopping GLP-1 Weight Loss Drugs Can Cause Rapid Weight Gain and Heart Risks

By BMJ Group January 12, 2026Uncategorized

Summary of Stopping GLP-1 Weight Loss Drugs Leads to Fast Rebound in Weight and Heart Risks, Study Warns: A recent study highlights that while weight loss medications, particularly GLP-1 receptor…